» Articles » PMID: 40073317

Pembrolizumab in Early-Stage Triple-Negative Breast Cancer

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2025 Mar 12
PMID 40073317
Authors
Affiliations
Soon will be listed here.